# Coya Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/coya-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:08.730534+00:00 | | Last reviewed | 2026-10-16T13:53:08.730534+00:00 | ## Identity - Legal name: Coya Therapeutics, Inc. - Display name: Coya Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T17:07:41.3054+00:00 | | Completeness | 0.409 | | Record Quality | 0.845 | | Directors | 7 | | Committees | 3 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anabella Villalobos, Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:5 - Ann Lee, Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:6 - Arun Swaminathan, Ph.D.: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:7 - Dieter Weinand: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:8 - Dov Goldstein, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:9 - Howard Berman, Ph.D.: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:10 - Wilbur L. Ross, Jr.: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:11 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Dieter Weinand (member, current). committee_id=alpha:committee:coya-therapeutics-inc:audit - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Dieter Weinand (member, current). committee_id=alpha:committee:coya-therapeutics-inc:audit-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Dieter Weinand. Members: Dieter Weinand (chair, current). committee_id=alpha:committee:coya-therapeutics-inc:nominating-and-governance ## Executive leadership - Arun Swaminathan, Ph.D.: Chief Executive Officer, Director [CEO]. Status: current. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:12 - David Snyder, MBA: Chief Financial Officer, Chief Operating Officer [CFO]. Status: current. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:13 - Fred Grossman, DO, FAPA: President, Chief Medical Officer [PRESIDENT]. Status: current. claim_id=alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:14 ## Governance events - CEO_CHANGED: Arun Swaminathan, Ph.D. executive of Coya Therapeutics, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:1c65n6heeoyw1 - CFO_CHANGED: David Snyder, MBA executive of Coya Therapeutics, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:j1m5891nachll - EXECUTIVE_APPOINTED: Fred Grossman, DO, FAPA executive of Coya Therapeutics, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:143r3xi1k9qaww - DIRECTOR_APPOINTED: Arun Swaminathan, Ph.D. seat on Coya Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:sns6b6mwm1uq - DIRECTOR_APPOINTED: Dieter Weinand seat on Coya Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:fmnrbyfhhr4a - DIRECTOR_APPOINTED: Wilbur L. Ross, Jr. seat on Coya Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:zs5lz04w0ipi - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Coya Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:1fj13481wnzhee - COMMITTEE_MEMBER_ADDED: Dieter Weinand member of Audit; Nominating and Governance · Chair, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:17et682e5558e - DIRECTOR_APPOINTED: Anabella Villalobos, Ph.D. seat on Coya Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:1scnxezq99nsp - DIRECTOR_APPOINTED: Ann Lee, Ph.D. seat on Coya Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:1jt2e9q1v369u6 - DIRECTOR_APPOINTED: Dov Goldstein, M.D. seat on Coya Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:1injjlz1i52r39 - DIRECTOR_APPOINTED: Howard Berman, Ph.D. seat on Coya Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:08.730534+00:00. event_id=alpha:event:transition:1217sp01bpyc3k ## Scoped resources - `alpha://company/coya-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record - `alpha://company/coya-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=identity - `alpha://company/coya-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/coya-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=board - `alpha://company/coya-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=committees - `alpha://company/coya-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=leadership - `alpha://company/coya-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=ownership - `alpha://company/coya-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=financials - `alpha://company/coya-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/coya-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=compensation - `alpha://company/coya-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=governance - `alpha://company/coya-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/coya-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=audit - `alpha://company/coya-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=legal - `alpha://company/coya-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=risk - `alpha://company/coya-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=cyber - `alpha://company/coya-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/coya-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=agents - `alpha://company/coya-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/coya-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=events - `alpha://company/coya-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=relationships - `alpha://company/coya-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=assessments - `alpha://company/coya-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:dieter-weinand","name":"Dieter Weinand"},"source_id":"board_seats"}` - Claim alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:dieter-weinand","name":"Dieter Weinand"},"source_id":"board_seats"}` ## Leadership - Anabella Villalobos, Ph.D.: Director. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9. - Ann Lee, Ph.D.: Director. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9. - Arun Swaminathan, Ph.D.: Director. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9. - Dieter Weinand: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9. - Dov Goldstein, M.D.: Director. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9. - Howard Berman, Ph.D.: Director. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9. - Wilbur L. Ross, Jr.: Director. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:11. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9. - Arun Swaminathan, Ph.D.: Chief Executive Officer, Director. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:12. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:56d8b26f0386067ee3297aacf03a988efb45ae69b921d8f82022defe720f9d0e. - David Snyder, MBA: Chief Financial Officer, Chief Operating Officer. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:13. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:48019c7688ed301590604d0ec65b25cbab831f4fd2c888ef922f396f9270c8c5. - Fred Grossman, DO, FAPA: President, Chief Medical Officer. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:14. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d3682fffd0997c1b73c26ac742a75ea0e0b1f075ed5f4aa698eb13616d376ae7. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Dieter Weinand. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3bd70789ea8a9cd8421bf2c068d97ae34c4a49929f32f7ba9a0455210bd14581. - Nominating and Governance: Chair Dieter Weinand; Members Dieter Weinand (Chair). Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3bd70789ea8a9cd8421bf2c068d97ae34c4a49929f32f7ba9a0455210bd14581. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Coya Therapeutics, Inc.. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b82bd85b7e97ff6e28495414acaa50d307b1627b3909034b60390794e9a6cc39. ## Entity Status - Public listing published. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b82bd85b7e97ff6e28495414acaa50d307b1627b3909034b60390794e9a6cc39. ## Published Fact - US. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b82bd85b7e97ff6e28495414acaa50d307b1627b3909034b60390794e9a6cc39. ## Committee Appointment - Dieter Weinand: member, Audit. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3bd70789ea8a9cd8421bf2c068d97ae34c4a49929f32f7ba9a0455210bd14581. - Dieter Weinand: chair, Nominating and Governance. Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3bd70789ea8a9cd8421bf2c068d97ae34c4a49929f32f7ba9a0455210bd14581. ## Security Listing - COYA (NASDAQ). Claim: alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b82bd85b7e97ff6e28495414acaa50d307b1627b3909034b60390794e9a6cc39. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:b82bd85b7e97ff6e28495414acaa50d307b1627b3909034b60390794e9a6cc39: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/coya-therapeutics-inc). - alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9: [Coya Therapeutics, Inc. DEF 14A 2025-05-16](https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm). - alpha:projection-evidence:document:56d8b26f0386067ee3297aacf03a988efb45ae69b921d8f82022defe720f9d0e: [COYA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm). - alpha:projection-evidence:document:48019c7688ed301590604d0ec65b25cbab831f4fd2c888ef922f396f9270c8c5: [COYA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm). - alpha:projection-evidence:document:d3682fffd0997c1b73c26ac742a75ea0e0b1f075ed5f4aa698eb13616d376ae7: [COYA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm). - alpha:projection-evidence:3bd70789ea8a9cd8421bf2c068d97ae34c4a49929f32f7ba9a0455210bd14581: [Audit](https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/coya-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/coya-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/coya-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T17:07:41.061238+00:00; recorded 2026-10-16T17:07:41.061238+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.